Schmitt M, Ewendt F, Kluttig A, Mikolajczyk R, Kraus FB, Wtjen W, et al
In modern healthcare, vitamin deficiencies are more common than many people realize
Key Takeaway: Reconstitution is the essential process of turning shelf-stable powder into an active, injectable liquid
According to NICE guideline NG28, GLP-1 receptor agonists should be considered when: Triple therapy (metformin and two other oral drugs) is not effective, not tolerated, or contraindicated The patient has a BMI 35 kg/m (or lower in people of Black, Asian and other minority ethnic groups) and specific obesity-related comorbidities The patient has a BMI 40% reduction in non-HDL cholesterol GLP-1 receptor agonist for glycaemic control and weight management (with secondary lipid benefits) Ezetimibe if non-HDL cholesterol reduction is insufficient Lifestyle interventions addressing diet, exercise, and weight Monitoring and follow-up are essential components of cholesterol management
Store drops as directed (typically in the original pharmacy container at room temperature)
Most patients tolerate the injections well